Affimed Shares Fall 32 percent on Clinical Update

AFMD Stock  USD 1.51  0.62  29.11%   
About 63% of Affimed NV's investor base is looking to short. The analysis of the overall investor sentiment regarding Affimed NV suggests that many traders are alarmed. The current market sentiment, together with Affimed NV's historical and current headlines, can help investors time the market. In addition, many technical investors use Affimed NV stock news signals to limit their universe of possible portfolio assets.
  
After disclosing revised clinical results for its AFM24atezolizumab combination treatment in non-small cell lung cancer, Affimed N.V. shares

Read at gurufocus.com
Gurufocus Stories at Macroaxis
  

Affimed NV Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Affimed NV can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Affimed NV Fundamental Analysis

We analyze Affimed NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Affimed NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Affimed NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Asset

Total Asset Comparative Analysis

Affimed NV is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Affimed NV Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Affimed NV stock to make a market-neutral strategy. Peer analysis of Affimed NV could also be used in its relative valuation, which is a method of valuing Affimed NV by comparing valuation metrics with similar companies.

Peers

Affimed NV Related Equities

HEPAHepion Pharmaceuticals   7.36   
0%
46.0%
CRVSCorvus Pharmaceuticals   7.10   
0%
45.0%
APTOAptose Biosciences   5.56   
0%
35.0%
AGENAgenus   4.59   
0%
29.0%
ADAPAdaptimmune Therapeutics   1.69   
0%
10.0%
PDSBPDS Biotechnology   0.51   
3.0%
0%
DAWNDay One   0.87   
5.0%
0%
ELEVElevation Oncology   1.73   
11.0%
0%
LPTXLeap Therapeutics   1.93   
12.0%
0%
MREOMereo BioPharma   2.65   
16.0%
0%
INZYInozyme Pharma   6.12   
39.0%
0%
ADCTADC Therapeutics   10.33   
65.0%
0%
XFORX4 Pharmaceuticals   13.36   
85.0%
0%
TERNTerns Pharmaceuticals   15.29   
97.0%
0%
PIRSPieris Pharmaceuticals   15.69   
100.0%
0%

Complementary Tools for Affimed Stock analysis

When running Affimed NV's price analysis, check to measure Affimed NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Affimed NV is operating at the current time. Most of Affimed NV's value examination focuses on studying past and present price action to predict the probability of Affimed NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Affimed NV's price. Additionally, you may evaluate how the addition of Affimed NV to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments